Specific multinutrient combination benefits patients with early stage Alzheimer’s disease

Posted · Add Comment
scidaily-logo-rss

A new longitudinal study has shown that a nutritional drink designated a ‘food for special medical purposes’ containing the multinutrient combination Fortasyn Connect® can benefit patients with the earliest stages of Alzheimer’s disease (AD), mild cognitive impairment, who are at risk of progressing to the dementia stage of AD.

This full article appears on <a href="https://www.sciencedaily.com/releases/2019/06/190612110125.htm">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *